Mr. Wang has over 20 years of experience in healthcare investment and private equity fund management, with healthcare sector expertise and outstanding investment track record.
Mr. Wang served as an executive director of CSPC Pharmaceutical Group (stock code: 1093) and a non-executive director of Consun Pharmaceutical Group (stock code: 1681). Mr. Wang worked as a core partner and managing director of Hony Capital from January 2005 to June 2015.
From 1997 to 2004, he was the head of planning management department of Shanghai Industrial Medical Technology (Group) Co., Ltd. (Hong Kong GEM, 8018.HK), senior corporate management manager of Shanghai Industrial Holdings Co., Ltd. (Hong Kong Main Board, 0363.HK).
Mr. Wang Shunlong works as the national overseas high-level talent introduction plan (thousands of people plan) evaluation experts. He is Vice President of Tsinghua Alumni Association Hong Kong, and also serves as a board member of Tsinghua Entrepreneur and Executive Club (TEEC) and Tsinghua Alumni Investment Association.
Mr. Wang graduated from Tsinghua University with a bachelor’s degree and a doctorate degree in Engineering. He also spent three years as a visiting scholar at Eindhoven University of Technology in Netherlands.